Home NDC 45861-005 Medrox-Rx
Product NDC 45861-005
11-digit product format 458610005
Labeler code 45861
Product ID 45861-005_0464d781-fa9d-442a-a7a7-94a3c8cf4786
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name methyl salicylate, menthol, capsaicin
Dosage form OINTMENT
Route TOPICAL
Labeler Pharmaceutica North America, Inc.
Application part348
Marketing category OTC MONOGRAPH FINAL
Marketing start 2011-10-27
Marketing end 0000-00-00
Substance METHYL SALICYLATE; MENTHOL; CAPSAICIN
Active strength 24 g/120g; g/120g; g/120g
NDC exclude flag E
Listing certified through 2017-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 44 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Code Status Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 45861-005-01 D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 45861-005-01 D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product D Discontinued by firm 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 45861-005-01 D Discontinued by firm 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product D Discontinued by firm a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 45861-005-01 D Discontinued by firm a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product D Discontinued by firm cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 45861-005-01 D Discontinued by firm cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product D Discontinued by firm cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 45861-005-01 D Discontinued by firm cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product I Inactivated by FDA 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 45861-005-01 I Inactivated by FDA 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product I Inactivated by FDA ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 45861-005-01 I Inactivated by FDA ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product I Inactivated by FDA 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 45861-005-01 I Inactivated by FDA 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product I Inactivated by FDA ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 45861-005-01 I Inactivated by FDA ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product I Inactivated by FDA 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 45861-005-01 I Inactivated by FDA 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product I Inactivated by FDA 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 45861-005-01 I Inactivated by FDA 557ba5c1ecfa…9c80585c8c6e…2024-05-28 21:12 UTC · source 2024-05-28 excluded product product I Inactivated by FDA 8af77b9d5b6f…d9bbb34c5368…2024-05-28 21:12 UTC · source 2024-05-28 excluded package package 45861-005-01 I Inactivated by FDA 8af77b9d5b6f…d9bbb34c5368…2024-05-15 03:39 UTC · source 2024-05-14 excluded product product I Inactivated by FDA 834df4deac94…adcc014656a3…2024-05-15 03:39 UTC · source 2024-05-14 excluded package package 45861-005-01 I Inactivated by FDA 834df4deac94…adcc014656a3…2024-03-11 06:39 UTC · source 2024-03-08 excluded product product I Inactivated by FDA 1332a3947898…d4bfe170f9cd…2024-03-11 06:39 UTC · source 2024-03-08 excluded package package 45861-005-01 I Inactivated by FDA 1332a3947898…d4bfe170f9cd…2022-08-30 03:57 UTC · source 2022-08-29 excluded product product I Inactivated by FDA fb8cb913e6d1…eb8c232b6be0…2022-08-30 03:57 UTC · source 2022-08-29 excluded package package 45861-005-01 I Inactivated by FDA fb8cb913e6d1…eb8c232b6be0…2022-04-09 23:13 UTC · source 2022-04-08 excluded product product I Inactivated by FDA 86f5da6cb304…a595104c45d7…2022-04-09 23:13 UTC · source 2022-04-08 excluded package package 45861-005-01 I Inactivated by FDA 86f5da6cb304…a595104c45d7…2022-04-04 05:40 UTC · source 2022-04-01 excluded product product I Inactivated by FDA bd6a592717d7…303034d00443…2022-04-04 05:40 UTC · source 2022-04-01 excluded package package 45861-005-01 I Inactivated by FDA bd6a592717d7…303034d00443…2021-12-27 23:28 UTC · source 2021-12-27 excluded product product I Inactivated by FDA 8dfbde2a14a4…c9ff85d89658…2021-12-27 23:28 UTC · source 2021-12-27 excluded package package 45861-005-01 I Inactivated by FDA 8dfbde2a14a4…c9ff85d89658…2020-12-18 03:04 UTC · source 2020-12-17 excluded product product I Inactivated by FDA e2bbac7714bc…27bdfed8d636…2020-12-18 03:04 UTC · source 2020-12-17 excluded package package 45861-005-01 I Inactivated by FDA e2bbac7714bc…27bdfed8d636…2020-06-10 20:45 UTC · source 2020-06-10 excluded product product I Inactivated by FDA 9bebd1f3094a…5416666fcb17…2020-06-10 20:45 UTC · source 2020-06-10 excluded package package 45861-005-01 I Inactivated by FDA 9bebd1f3094a…5416666fcb17…2019-12-08 06:16 UTC · source 2019-12-05 excluded product product I Inactivated by FDA 110d247fa046…a55b01930146…2019-12-08 06:16 UTC · source 2019-12-05 excluded package package 45861-005-01 I Inactivated by FDA 110d247fa046…a55b01930146…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
FDA-Initiated Inactive NDC Indexing# DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded capsaicin ACTIVE INGREDIENT S07O44R1ZM MEDROX-RX (METHYL SALICYLATE, MENTHOL, CAPSAICIN) OINTMENT [PHARMACEUTICA NORTH AMERICA, INC.] 8 menthol ACTIVE INGREDIENT L7T10EIP3A MEDROX-RX (METHYL SALICYLATE, MENTHOL, CAPSAICIN) OINTMENT [PHARMACEUTICA NORTH AMERICA, INC.] 8 methyl salicylate ACTIVE INGREDIENT LAV5U5022Y MEDROX-RX (METHYL SALICYLATE, MENTHOL, CAPSAICIN) OINTMENT [PHARMACEUTICA NORTH AMERICA, INC.] 8 capsaicin ACTIVE MOIETY S07O44R1ZM MEDROX-RX (METHYL SALICYLATE, MENTHOL, CAPSAICIN) OINTMENT [PHARMACEUTICA NORTH AMERICA, INC.] 8 menthol ACTIVE MOIETY L7T10EIP3A MEDROX-RX (METHYL SALICYLATE, MENTHOL, CAPSAICIN) OINTMENT [PHARMACEUTICA NORTH AMERICA, INC.] 8 methyl salicylate ACTIVE MOIETY LAV5U5022Y MEDROX-RX (METHYL SALICYLATE, MENTHOL, CAPSAICIN) OINTMENT [PHARMACEUTICA NORTH AMERICA, INC.] 8 ALOE VERA LEAF INACTIVE INGREDIENT ZY81Z83H0X MEDROX-RX (METHYL SALICYLATE, MENTHOL, CAPSAICIN) OINTMENT [PHARMACEUTICA NORTH AMERICA, INC.] 8 CARBOMER COPOLYMER TYPE A INACTIVE INGREDIENT 71DD5V995L MEDROX-RX (METHYL SALICYLATE, MENTHOL, CAPSAICIN) OINTMENT [PHARMACEUTICA NORTH AMERICA, INC.] 8 CETYL ALCOHOL INACTIVE INGREDIENT 936JST6JCN MEDROX-RX (METHYL SALICYLATE, MENTHOL, CAPSAICIN) OINTMENT [PHARMACEUTICA NORTH AMERICA, INC.] 8 ETHYLHEXYLGLYCERIN INACTIVE INGREDIENT 147D247K3P MEDROX-RX (METHYL SALICYLATE, MENTHOL, CAPSAICIN) OINTMENT [PHARMACEUTICA NORTH AMERICA, INC.] 8 FD&C BLUE NO. 1 INACTIVE INGREDIENT H3R47K3TBD MEDROX-RX (METHYL SALICYLATE, MENTHOL, CAPSAICIN) OINTMENT [PHARMACEUTICA NORTH AMERICA, INC.] 8 FD&C YELLOW NO. 5 INACTIVE INGREDIENT I753WB2F1M MEDROX-RX (METHYL SALICYLATE, MENTHOL, CAPSAICIN) OINTMENT [PHARMACEUTICA NORTH AMERICA, INC.] 8 GLYCERIN INACTIVE INGREDIENT PDC6A3C0OX MEDROX-RX (METHYL SALICYLATE, MENTHOL, CAPSAICIN) OINTMENT [PHARMACEUTICA NORTH AMERICA, INC.] 8 ISOPROPYL MYRISTATE INACTIVE INGREDIENT 0RE8K4LNJS MEDROX-RX (METHYL SALICYLATE, MENTHOL, CAPSAICIN) OINTMENT [PHARMACEUTICA NORTH AMERICA, INC.] 8 PEG-150 DISTEARATE INACTIVE INGREDIENT 6F36Q0I0AC MEDROX-RX (METHYL SALICYLATE, MENTHOL, CAPSAICIN) OINTMENT [PHARMACEUTICA NORTH AMERICA, INC.] 8 PHENOXYETHANOL INACTIVE INGREDIENT HIE492ZZ3T MEDROX-RX (METHYL SALICYLATE, MENTHOL, CAPSAICIN) OINTMENT [PHARMACEUTICA NORTH AMERICA, INC.] 8 POLYSORBATE 20 INACTIVE INGREDIENT 7T1F30V5YH MEDROX-RX (METHYL SALICYLATE, MENTHOL, CAPSAICIN) OINTMENT [PHARMACEUTICA NORTH AMERICA, INC.] 8 SODIUM LAURYL SULFATE INACTIVE INGREDIENT 368GB5141J MEDROX-RX (METHYL SALICYLATE, MENTHOL, CAPSAICIN) OINTMENT [PHARMACEUTICA NORTH AMERICA, INC.] 8 TROLAMINE INACTIVE INGREDIENT 9O3K93S3TK MEDROX-RX (METHYL SALICYLATE, MENTHOL, CAPSAICIN) OINTMENT [PHARMACEUTICA NORTH AMERICA, INC.] 8 WATER INACTIVE INGREDIENT 059QF0KO0R MEDROX-RX (METHYL SALICYLATE, MENTHOL, CAPSAICIN) OINTMENT [PHARMACEUTICA NORTH AMERICA, INC.] 8